Bellicum Pharmaceuticals Announces Proposed $53.0 Million Public Offering of Preferred Stock and Warrants with Concurrent Private Placement Read more about Bellicum Pharmaceuticals Announces Proposed $53.0 Million Public Offering of Preferred Stock and Warrants with Concurrent Private Placement
Bellicum Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Operational Update Read more about Bellicum Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Operational Update
Bellicum Pharmaceuticals Announces Rivo-cel™ Achieves Primary Endpoint in Pediatric Registrational Trial Read more about Bellicum Pharmaceuticals Announces Rivo-cel™ Achieves Primary Endpoint in Pediatric Registrational Trial
Bellicum Pharmaceuticals Provides Interim Data for BPX-601 in Patients with Metastatic Pancreatic Cancer for Presentation at ASCO Annual Meeting Read more about Bellicum Pharmaceuticals Provides Interim Data for BPX-601 in Patients with Metastatic Pancreatic Cancer for Presentation at ASCO Annual Meeting
Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Read more about Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Bellicum Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference Read more about Bellicum Pharmaceuticals to Present at Jefferies 2019 Healthcare Conference
Bellicum Pharmaceuticals to Present Updated Results for BPX-601 at the 2019 ASCO Annual Meeting Read more about Bellicum Pharmaceuticals to Present Updated Results for BPX-601 at the 2019 ASCO Annual Meeting
Bellicum Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Operational Update Read more about Bellicum Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Operational Update
Bellicum Pharmaceuticals to Participate in Jefferies 6th Annual IO Cell Therapy Summit Read more about Bellicum Pharmaceuticals to Participate in Jefferies 6th Annual IO Cell Therapy Summit
Bellicum Pharmaceuticals Provides Operational Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2018 Read more about Bellicum Pharmaceuticals Provides Operational Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2018